Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.3 | 2.1 | 2.3 | 1,919.7 |
| Revenue growth | -84.8% | -10.0% | -99.9% | |
| Cost of goods sold | 0.2 | 1.2 | 1.3 | 1,223.0 |
| Gross profit | 0.2 | 0.9 | 1.0 | 696.7 |
| Gross margin | 50.1% | 44.6% | 44.6% | 36.3% |
| Research and development | 36.3 | 26.5 | 15.0 | 4,278.9 |
| General and administrative | 15.6 | 8.3 | 3.1 | 2,708.9 |
| EBITA | -51.7 | -33.9 | -17.1 | -6,291.0 |
| EBITA margin | -16316.3% | -1629.2% | -739.0% | -327.7% |
| Amortization of intangibles | 0.0 | | | |
| EBIT | -51.7 | -33.9 | -17.1 | -6,291.0 |
| EBIT margin | -16325.8% | -1629.2% | -739.0% | -327.7% |
| Pre-tax income | -50.5 | -33.8 | -17.0 | -7,709.4 |
| Income taxes | 0.0 | -0.3 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.9% | 0.0% | 0.0% |
| Net income | -50.5 | -33.5 | -17.0 | -7,709.4 |
| Net margin | -15937.3% | -1612.3% | -737.2% | -401.6% |
| |
| Diluted EPS | ($1.91) | ($2.46) | ($3.44) | ($2.18) |
| Shares outstanding (diluted) | 26.4 | 13.6 | 5.0 | 3,535.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|